Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression profiling.

Endocrine
Katharina H RuebelRicardo V Lloyd

Abstract

The pathogenesis of pituitary adenomas and many of the genes influencing growth of these tumors are unknown. TGFbeta is known to inhibit proliferation of cultured anterior pituitary cells and anterior pituitary tumors, but the signal transduction pathways involved in the inhibition of growth are unclear. We treated the human HP75 pituitary cell line with 10(-9) M TGFbeta1 for 4, 24, and 96 h and performed global gene expression profiling by Affymetrix GeneChip microarray analysis. Quantitative PCR validation of specific genes involved in the TGFbeta1-induced regulation of pituitary cell growth was also done. Of the 15,000 genes queried, there were 37 genes up-regulated and 48 genes down-regulated twofold or more after 4 h of TGFbeta1 treatment. There were 121 genes up-regulated and 109 genes down-regulated twofold or more after 24 h of TGFbeta1 treatment and 112 genes up-regulated and 43 genes down-regulated twofold or more after 96 h of TGFbeta1 treatment. Galectin-3 (Gal-3) protein was decreased by TGFbeta1 treatment and several genes which interacted with Gal-3 including RUNX1 and WNT5B were up-regulated after TGFbeta1 treatment. SOX4 was also up-regulated by TGFbeta1 treatment. SMAD3, which is directly involved in the TGFbe...Continue Reading

References

Oct 6, 1998·Annual Review of Biochemistry·J Massagué
Sep 22, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·B K ZehentnerH Burtscher
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·C KjellmanB Widegren
Aug 4, 2001·Molecular and Cellular Biology·J DangA T Look
Oct 5, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·H UusitaloE Vuorio
Oct 14, 2003·Oncogene·Anny KretschmerAnke Klippel
Oct 15, 2003·Nature Reviews. Cancer·Peter M Siegel, Joan Massagué
Mar 24, 2004·Mechanisms of Development·Kelly B ChaSally A Camper
Dec 30, 2004·The Journal of Biological Chemistry·Takayuki FurumatsuHiroshi Asahara
May 4, 2005·Cancer Research·Tatsuo ShimuraAvraham Raz
Nov 18, 2005·Cytokine & Growth Factor Reviews·Brian Bierie, Harold L Moses
Dec 3, 2005·Genes & Development·Joan MassaguéDavid Wotton
May 27, 2006·Science·Outi VierimaaLauri A Aaltonen
Jun 24, 2006·Nature Reviews. Cancer·Brian Bierie, Harold L Moses
Aug 12, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Yanna CaoTien C Ko

❮ Previous
Next ❯

Citations

Aug 10, 2011·Clinical Nuclear Medicine·Charles IntenzoDavid M Capuzzi
Jan 17, 2009·Cancer Research·Christopher D ScharerCarlos S Moreno
Apr 10, 2013·Epigenomics·Ratnam S SeelanRobert M Greene
Feb 24, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lei Wang, Xiu-Li Guo
Oct 19, 2017·Pathology Oncology Research : POR·O DarvasiHenriett Butz
Sep 29, 2019·Medical Oncology·Hongyan DongBo Han
Jun 20, 2020·Frontiers in Neuroendocrinology·Pedro MarquesMárta Korbonits

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.